DaVita (DVA) Reports In-Line Q2 EPS; offers guidance
Tweet
Share
E-mail
Get Alerts DVA Hot Sheet
Price: $180.05 +1.27%
Financial Fact:
Goodwill impairment charge: 0
Today's EPS Names:
EGRX, VAXX, AFIB, More
Financial Fact:
Goodwill impairment charge: 0
Today's EPS Names:
EGRX, VAXX, AFIB, More
Join SI Premium – FREE
DaVita (NYSE: DVA) reported Q2 EPS of $2.59, in-line with the analyst estimate of $2.59. Revenue for the quarter came in at $3.19 billion versus the consensus estimate of $3.15 billion.
GUIDANCE:
DaVita sees FY2024 EPS of $9.25-$10.05, versus the consensus of $9.55.
For earnings history and earnings-related data on DaVita (DVA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Phibro Animal Health (PAHC) Tops Q4 EPS by 13c; Offers Guidance
- Raymond James Starts Hanover Bancorp, Inc. (HNVR) at Market Perform
- Raymond James Starts Kearny Financial (KRNY) at Outperform
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
